Why the study?
Does a beta-adrenergic receptor blocking agent improve symptoms in an adult with Noonan syndrome and biventricular hypertrophic cardiomyopathy causing right ventricular outflow tract obstruction?
Does a beta-adrenergic receptor blocking agent improve symptoms in an adult with Noonan syndrome and biventricular hypertrophic cardiomyopathy causing right ventricular outflow tract obstruction?
Beta-blocker therapy may be effective for symptom relief in rare adult cases of Noonan syndrome with biventricular hypertrophic cardiomyopathy and isolated right ventricular outflow tract obstruction.
May relieve symptoms in rare adult Noonan syndrome with biventricular HCM and RVOTO; leaves open efficacy in this population.
This report describes an adult patient with Noonan syndrome accompanied by biventricular hypertrophic cardiomyopathy causing isolated right ventricular outflow tract obstruction. Biventricular hypertrophic cardiomyopathy causing right- and/or left-side outflow tract obstruction, as well as valvular pulmonary stenosis, is relatively common in infants with Noonan syndrome. However, this condition without a dysplastic pulmonary valve, or indeed any polyvalvular dysplasia, is rare in adults with Noonan syndrome. Treatment with a beta-adrenergic receptor blocking agent improved the patient's symptoms. Because neither the etiologic and prognostic relationship nor the genetic linkage between hypertrophic cardiomyopathy associated with Noonan syndrome and non-syndromic hypertrophic cardiomyopathy is clearly defined, clinicopathological findings and further follow-up may provide important evidence for the pathogenesis of hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: